Pancreatic Cancer Research

ResearcherKagawa UniversityNo recent work listed

Yuki Shibayama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9318-7801; OpenAlex author ID A5008167665. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers

Papers 3

  1. Aberrant (pro)renin receptor expression induces genomic instability in pancreatic ductal adenocarcinoma through upregulation of SMARCA5/SNF2H. Co-author DOI 10.1038/s42003-020-01434-x↗
  2. Antiproliferative Effects of Monoclonal Antibodies against (Pro)Renin Receptor in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-19-0228↗
  3. (Pro)renin receptor is crucial for Wnt/β-catenin-dependent genesis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/srep08854↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akira Nishiyama · 3 shared papers, 2015–2020 · strength 0.23
  2. Tsutomu Masaki · 3 shared papers, 2015–2020 · strength 0.23
  3. Asadur Rahman · 2 shared papers, 2020 · strength 0.18
  4. Shinichi Yachida · 2 shared papers, 2015–2020 · strength 0.13
  5. Toru Furukawa · 1 shared paper, 2020 · strength 0.09
  6. Yasuyuki Suzuki · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.